United Therapeutics (UTHR) Tops Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $497.97 --0%
EPS Growth %: -10.1%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CULP, KFY, NNOX, More
EPS Growth %: -10.1%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CULP, KFY, NNOX, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $6.63, $0.10 better than the analyst estimate of $6.53. Revenue for the quarter came in at $794.4 million versus the consensus estimate of $728.34 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) call put ratio 2 calls to 1 put into quarter results
- GameStop (GME) Tops Q2 EPS by 8c
- Activist investor presses Xerox to review financial services arm - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
